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ABSTRACT
INTRODUCTION: Antimicrobial stewardship programmes 
recommend use of narrow-spectrum antibiotics as first-line 
treatment of childhood pneumonia in secondary care. The 
primary aim of the present study was to assess whether 
current guidelines are followed. A secondary aim was to 
assess if tracheal aspiration is a useful tool in the 
diagnostic process of suspected childhood pneumonia. 
METHODS: This was a retrospective descriptive single-
centre cohort study. Children between three months and 17 
years with a pneumonia diagnosis were included. The 
children were divided into two groups based on whether or 
not they had been treated with antibiotics (TWA) by their 
general practitioner. We obtained information on blood 
samples, treatment and microbial findings. Finally, we 
compared the use of antibiotics and the microbiological 
diagnosis of children TWA prior to admittance with those of 
drug-naïve children (DN). 
RESULTS: Guidelines were followed in 55% (n = 78) of the 
cases, which is comparable to results reported by other 
studies. Tracheal aspiration culture identified a bacterial 
pathogen in 54% (n = 77) of the cases; Haemophilus 
influenzae was the most prevalent. A larger percentage of 
tracheal aspirations was positive in the TWA group than in 
the DN group (66%; n = 31 versus 48%; n = 46). 
CONCLUSIONS: Compliance with local guidelines was 
comparable to findings reported in similar single-centre 
studies. Airway aspiration may be a useful supplement to 
other investigations.
FUNDING: none.
TRIAL REGISTRATION: not relevant.
Community-acquired pneumonia (CAP) is a common 
cause of morbidity in children under five years of age 
[1, 2]. In many countries, including Denmark, respir-
atory infections are diagnosed and managed in primary 
care [3]; even so, CAP is a common cause of hospital 
admission in children [4].
The clinical presentation of CAP is often non-spe-
cific in young children [4], and bacterial and viral 
pneumonia may be clinically indistinguishable [3]. 
Empirical antibiotic therapy based on clinical presenta-
tion is therefore commonly applied [2, 3].
Since antibiotic treatment selects for antibiotic re-
sistance, it is important to limit exposure to any anti-
biotic. Furthermore, it is difficult to identify the caus-
ative microorganisms and therefore to standardise the 
management of paediatric CAPs.  At the time of the  
present study, lower airway aspiration culture was in-
cluded as a diagnostic modality in local guidelines at 
the investigated centre [5], but airway aspiration cul-
ture was not recommended in current international 
guidelines [1, 3, 6]. Current Danish and international 
guidelines for treatment of CAP recommend the use of 
narrow-spectrum antibiotics as first-line treatment in 
both outpatients and hospitalised patients for children 
above three months of age [1, 3, 6]. This strategy has 
been confirmed by several studies showing comparable 
clinical outcomes of narrow-spectrum and broad-spec-
trum antibiotics for hospitalised children with CAP [7, 
8]. In contrast, guidelines regarding non-responders to 
first-line treatment in CAP are not well established [9].
The primary goal of antimicrobial stewardship pro-
grammes is to improve patient outcome while reducing 
the negative consequences of antimicrobial treatment 
[10, 11]. Secondary goals include reduction of anti-
biotic acquisition costs. The two core strategies recom-
mended to accomplish these goals are: 1) formulary re-
striction with preauthorisation and 2) prospective audit 
of antimicrobial use with immediate feedback to pre-
scribers [10].
The aim of the present study was to analyse if child-
hood CAP is being treated according to local guidelines 
which recommend penicillin as first-line treatment.  
A second aim was to test the hypothesis that airway as-
piration culture would be a better tool than blood cul-
ture for effectively guiding the choice of antibiotic re-
gime. Children treated with antibiotics (TWA) prior to 
admittance were compared to drug-naïve children 
(DN). The samples from the DN group were expected 
to record a higher number of pathogens than the other 
group. 
 
METHODS
This was a retrospective cohort study on inpatients ad-
mitted to the Department of Paediatrics at Herlev Hos-
pital, Denmark. Information about the subjects is pro-
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tected in accordance with the Danish Act on Processing 
of Personal Data. The study was approved by the Dan-
ish Data Protection Agency (r. no. 2007-58-0015).
The cohort was obtained as shown in Figure 1. All 
children between one month and 17 years of age who 
had been TWA between January and March 2012 were 
screened for inclusion. Children who received drugs 
given strictly as prophylaxis were excluded. Patients di-
agnosed with pneumonia at discharge were included in 
the final cohort. The final cohort was divided into two 
groups: 1) Children who had been TWA prescribed by a 
general practitioner before admission to hospital and 
2) Children who were DN. 
We identified the children through the Electronic 
Patient Medication module, which holds information 
on all in-hospital drug administrations. Information on 
drugs prescribed by the general practitioner was ob-
tained from the unified Danish eHealth Portal, where it 
is possible to identify prescribed drugs dispensed at 
community pharmacies. 
Information on biochemical parameters was ob-
tained from the clinical laboratory information system 
LABKA. Information on microbiological findings (blood 
culture, airway aspiration culture) was gathered from 
the laboratory information system wwBakt. Patient re-
cords were reviewed in the electronic patient-continu-
ation system OPUS.  
We performed chart-audits on all patients. Baseline 
information included date of birth, sex, date of diagno-
sis, length of stay (LOS) in hospital, vital parameters at 
admittance (temperature, respiration frequency, heart 
rate, oxygen saturation) and prescribed antibiotics be-
fore and after admittance.
Vital parameters that are age-specific, respiration 
frequency and heart rate were stratified into age- 
defined subgroups (one month to one year of age,  
> 1 year to 11 years of age and > 11 years of age). 
Biochemical parameters (white blood cell count (WBC) 
and C-reactive protein (CRP)) were registered. CRP 
levels within the normal range (< 10 mg/l) were listed 
as 0. Results from blood and airway aspiration culture 
were registered.
The initial empiric antibiotic therapy was compared 
to antibiotics given at discharge in order to analyse 
whether microbial findings in airway aspiration and 
blood culture led to a change in treatment.
To distinguish narrow-spectrum from broad-spec-
trum treatment, antibiotics prior to admittance were 
divided into three groups: penicillin, amoxicillin (with/
without clavulanic acid) and others.
Descriptive statistics were used, and results were 
summarised as median and range for continuous vari-
ables, and as percentages for nominal variables. 
Data management and all statistical analyses were 
performed using SAS, version 9.4 (SAS Institute, Cary, 
N.C.). 
Trial registration: not relevant.
RESULTS
Clinical characteristics of the patients
A total of 152 patients between one month and 17 
years of age with pneumonia were included. The 
youngest patient was three months old. Demographic 
data are shown in Table 1. The mean age was 3.8 
years, and 81 (53%) of the children were boys. A total 
of 141 (93%) of the patients admitted were under 11 
years of age. There was no difference in LOS between 
sexes. 
The median CRP at time of admittance was 14 mg/l 
for girls and 5 mg/l for boys (reference range: 0-10 
mg/l). The median WBC was 11.6 × 103/µl for both 
males and females (reference range: 4.5 × 103 – 11 × 
103/µl).
Blood culture was performed in 58 cases (38%). Of 
these, only four were positive. The findings included: 
Staphylococcus hominis, Staphylococcus warneri, Strep­
tococcus parasanguinis and “different streptococcus and 
staphylococcus species”. The authors found it most 
likely that these isolates represented a contamination 
of the sample. 
Airway aspiration and X-ray 
Airway aspiration culture was performed from 142 pa-
tients out of a total of 152 patients (93%). No airway 
aspiration was performed for the remaining ten pa-
tients. One or more potential pathogens were identified 
in 54% (n = 77) of the cases. The airway aspiration 
cultures were divided into a DN and a TWA group. In 
the TWA group, a pathogen was found in 66% (n = 31) 
of the cases. In the DN group, a pathogen was found in 
48% (n = 46). 
Pneumonia is a com­
mon cause of morbid­
ity in young children. 
Colourbox.
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Haemophilus influenzae was the most prevalent  
microorganism identified in both groups of airway as-
piration culture. It appeared in 61% (n = 47) of the 
positive cases and as a monoculture in 39% (n = 30). 
Moraxella catarrhalis was identified in 32% (n = 25) of 
the positive cases, and as a monoculture in 12% (n = 
9). Streptococcus pneumoniae was isolated in 17% (n = 
13) of the positive cases, monoculture in 5% (n = 4).
Chest X-ray (CXR) was performed in 95% (n = 145) 
of cases. Only 6% (n = 8) were described as normal. In 
all, 48/145 patients (33% of the CXR-positive patients) 
had findings that were positive for bilateral lung con-
solidation; 42/145 patients (29% of the CXR-positive 
patients) had findings that were positive for unilateral 
consolidations. Only one patient showed pleural effu-
sion. The rest had primarily perihilar linear opacities or 
consolidation 29/145 (20%).
Treatment with antibiotics in primary care  
and after admittance
Table 2 presents the type of antibiotics prescribed be-
fore and at admittance at the Department of Paediatrics 
in the 142 cases with airway aspirations.
Penicillin was the most frequently prescribed drug 
during admission (55%, n = 78), followed by clarithro-
mycin (13%, n = 18), amoxicillin (11%, n = 16), ce-
furoxime (10%, n = 14), amoxicillin with clavulanic 
acid (6%, n = 9) and other antibiotics (5%, n = 7).
Overall, broad-spectrum antibiotics at admittance 
(cefuroxime, clarithromycin and others) were pre-
scribed in 27% of all cases. For the TWA group, the pre-
scription rate was 28% and for the DN group 27%. 
We investigated the association between the micro-
organisms and the antibiotics that the patients received 
when discharged from the hospital. Out of 14 (30%) di-
agnosed with H. influenzae in monoculture in the DN 
group, eight were discharged with amoxicillin and five 
with amoxicillin with clavulanic acid. Among the 16 
patients in the TWA with H. influenzae in monoculture, 
five were discharged with amoxicillin and three with 
amoxicillin with clavulanic acid. In total, 43% (n = 13) 
of the children with H. influenzae in monoculture were 
treated with amoxicillin at discharge.
Patients with a M. catarrhalis monoculture were dis-
charged with amoxicillin with clavulanic acid in three 
out of nine cases.
When S. pneumoniae was identified in monoculture, 
three out of four of the children were discharged with 
penicillin. 
DISCUSSION
Local clinical guidelines were followed in 55% of the 
cases where penicillin was used as first-line treatment 
on admission. This is comparable to results reported 
from multiple international surveys: In a British review 
comprising three years of national data, the recom-
mended first-line treatment (amoxicillin) was pre-
scribed in only 17.6-21.1% of the cases [12]. In a  
similar single-centre report from the USA, the recom-
mended first-line drug (ampicillin) was prescribed in 
63% of the cases [13]. 
CXR was performed in almost all cases, although 
guidelines [7] do not recommend routine CXR in un-
complicated CAP, since viral, bacterial or atypical or-
ganisms such as Chlamydia or Ureaplasma are indistin-
guishable on the basis of radiographic findings [14]. 
In the current guidelines from the British Thoracic 
Society, microbiological investigations are recom-
mended only in severe cases, and airway aspiration is 
TABLE 1
General clinical characteristics of the study population. The values are median (range).
Female
(n = 71 (47%))
Male
(n = 81 (53%))
total
(N = 152)
Age, yrs 2.0 (0.3-17.8) 1.7 (0.2-16.2) 3.8 (0.2-17.8)
LOS, days 4.0 (1-14) 4.0 (1-11) 4.0 (1-14)
SAT, % 94 (82-100) 95 (75-100) 95
Temperature, °C 38.9 (36.5-40.6) 38.4 (36.4-41.5) 38.7 (36.4-41.5)
Respiratory rate, /min.
1 mo.-1 yr 60.0 (36-75) 52.0 (30-100) 52 (30-100)
(n = 29)
1-11 yrs 50 (18-82) 40 (18-80) 44
(n = 112)
> 11 yrs 37 (22-52) 28 (24-33) 28
(n = 11)
Heart rate, /min.
1 mo.-1 yr 163 (140-184) 156.5 (125-190) 159
1-11 yrs 152 (113-200) 148.5 (88-203) 150
> 11 yrs 118.5 (97-140) 119 (78-138) 119
WBC, × 103/µl 11.6 (4.1-29.8) 11.6 (3.8-37.3) 11.6a
CRP concentration, mg/l 14 (0-187) 5 (0-305) 9.0
CRP = C-reactive protein; LOS = length of stay; SAT = oxygen saturation in the blood;  
WBC = white blood cell count.
a) Reference: 4.5-16.3 × 103/µl. 
FIGURE 1
Flow chart of how the cohort was obtained.
Discharged with a diagnosis 
of pneumonia
(N = 152)
Treated with antibiotics 
before admission 
(n = 47)
Drug-naïve 
(n = 95)
No information on treatment
(n = 10) 
Children > 1 month  
treated with  
antibiotics
Antibiotics given as  
prophylaxis: excluded
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not mentioned [3]. Blood culture is, however, recom-
mended even though the rate of positive findings is 
very low [1, 4]. A Finnish study found two positive 
blood cultures compared to 16 positive lung aspirates 
in 34 patients [15]. In this study, less than 7% of the 
blood cultures tested positive, but they were not clin-
ically relevant since the positive result was very likely 
due to contamination. In other studies, bacteraemia is 
also rarely found [1, 4, 15].
In contrast, one or more potential pathogens were 
identified in 54% of the airway aspiration cultures. 
There is a risk that the aspirations contain upper-air-
way material instead of the intended lower-airway ma-
terial. Since upper respiratory tract secretions often in-
clude bacteria that are commonly responsible for 
pneumonia [1], this is an important consideration 
when evaluating the results.
S. pneumoniae is considered the main cause of bac-
terial childhood CAP [3] even in the post-pneumococ-
cus vaccine era [16]. We found that H. influenzae was 
the most isolated pathogen followed by M. catarrhalis. 
This can most easily be explained in the TWA group, 
since these patients have often been treated with peni-
cillin prior to their admission. It has also been shown in 
another study that H. influenzae was the most common 
pathogen among children with CAP who had previ-
ously been TWA [17]. The high rate of H. influenzae in 
the DN group indicates that S. pneumoniae may not be 
as frequent as expected, at least not in hospitalised chil-
dren. To the best of our knowledge, this has not been 
reported in previous studies [12]. 
M. catharrhalis has not previously been shown to 
cause pneumonia in otherwise healthy children, and 
the finding in this study may simply be a result of con-
tamination from the upper airways. However, the mi-
croorganism is acknowledged as a common pathogen 
in other infections in children, such as otitis media and 
sinusitis [18], and we have chosen to include it as a po-
tential pathogen in the present study. 
Children in the TWA group presented with a  
higher percentage of positive aspirations than the  
other group. Possibly, the antibiotic treatment that  
the children received in the primary care setting se-
lected for an extended growth of the bacteria found in 
the aspirations.
A limitation in our study is the lack of viral diagno-
sis. Viral infection has been shown to account for 45-
63.4% of pneumonias in hospitalised children [19], but 
viral infection is clinically distinguishable from bacter-
ial infection [3]. There is also an indication that mixed 
viral and bacterial infections are common.
An older Danish study found no reason to treat in-
fants and young children with antibiotics since there 
was no difference in their tracheal secretions and the 
course of acute disease when the authors compared 
children who were given antibiotics with children who 
did not receive antimicrobial treatment [20]. This 
raises an important question about the value of airway 
aspiration and even antibiotics in young children. 
Another limitation of the present study is that we 
relied on diagnoses given to children at discharge.  
We used no objective criteria to establish the diagnosis. 
On the other hand, pneumonia is a clinical diagnosis 
[3, 6], and discharge diagnoses are given retrospect-
ively with all information available.
We obtained no information about suspected al-
lergy reactions towards penicillin or the presence of 
chronic pulmonary disease. Both might explain why 
broad-spectrum antibiotics were chosen in some of the 
cases, and chronic pulmonary disease could lead to a 
pathogen shift in the individual. Finally, the relatively 
limited size of the cohort might cause selection bias.
CONCLUSIONS 
Compliance with local guidelines was comparable to 
the findings reported in similar single-centre studies 
but may be further improved. In the present study, we 
did not find that blood culture was diagnostic of CAP. 
Airway aspiration may be useful as a supplement to 
other investigations. 
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TABLE 2
Choice of treatment with antibiotics prior to and after admittance to hospital. The values are n.
After admittance
 
Prior to admittance
penicillin  
(n = 78)
amoxicillin  
(n = 16)
amoxicillin with clavulanic acid  
(n = 9)
cefuroxime  
(n = 14)
clarithromycin  
(n = 18)
other antibiotics  
(n = 7)
total  
(N = 142)
Penicillin 16   6 3 3   5 1 34
Amoxicillin with clavulanic acid – – 2 – – –   2
Other   6 – 1 2   2 – 11
None 56 10 3 9 11 6 95
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